Pharmacodynamic (PD) Biomarkers Market, Global Outlook and Forecast 2022-2028

May 2022 | 63 pages | ID: PBD078271C50EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Pharmacodynamic (PD) Biomarkers in Global, including the following market information:

Global Pharmacodynamic (PD) Biomarkers Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Pharmacodynamic (PD) Biomarkers market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Exposure Biomarkers Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Pharmacodynamic (PD) Biomarkers include Thermo Fisher Scientific, Merck, Bio-Rad Laboratories, QIAGEN, Roche, Danaher Corporation, Siemens Healthcare, Abbott and Agilent Technologies. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pharmacodynamic (PD) Biomarkers companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Pharmacodynamic (PD) Biomarkers Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Pharmacodynamic (PD) Biomarkers Market Segment Percentages, by Type, 2021 (%)

• Exposure Biomarkers
• Effect Biomarkers
• Susceptibility Biomarkers

Global Pharmacodynamic (PD) Biomarkers Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Pharmacodynamic (PD) Biomarkers Market Segment Percentages, by Application, 2021 (%)

• Diagnostics
• Drug Discovery
• Personalized Medicine
• Others

Global Pharmacodynamic (PD) Biomarkers Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Pharmacodynamic (PD) Biomarkers Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Pharmacodynamic (PD) Biomarkers revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Pharmacodynamic (PD) Biomarkers revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Thermo Fisher Scientific
• Merck
• Bio-Rad Laboratories
• QIAGEN
• Roche
• Danaher Corporation
• Siemens Healthcare
• Abbott
• Agilent Technologies

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Pharmacodynamic (PD) Biomarkers Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Pharmacodynamic (PD) Biomarkers Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PHARMACODYNAMIC (PD) BIOMARKERS OVERALL MARKET SIZE

2.1 Global Pharmacodynamic (PD) Biomarkers Market Size: 2021 VS 2028
2.2 Global Pharmacodynamic (PD) Biomarkers Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Pharmacodynamic (PD) Biomarkers Players in Global Market
3.2 Top Global Pharmacodynamic (PD) Biomarkers Companies Ranked by Revenue
3.3 Global Pharmacodynamic (PD) Biomarkers Revenue by Companies
3.4 Top 3 and Top 5 Pharmacodynamic (PD) Biomarkers Companies in Global Market, by Revenue in 2021
3.5 Global Companies Pharmacodynamic (PD) Biomarkers Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pharmacodynamic (PD) Biomarkers Players in Global Market
  3.6.1 List of Global Tier 1 Pharmacodynamic (PD) Biomarkers Companies
  3.6.2 List of Global Tier 2 and Tier 3 Pharmacodynamic (PD) Biomarkers Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Pharmacodynamic (PD) Biomarkers Market Size Markets, 2021 & 2028
  4.1.2 Exposure Biomarkers
  4.1.3 Effect Biomarkers
  4.1.4 Susceptibility Biomarkers
4.2 By Type - Global Pharmacodynamic (PD) Biomarkers Revenue & Forecasts
  4.2.1 By Type - Global Pharmacodynamic (PD) Biomarkers Revenue, 2017-2022
  4.2.2 By Type - Global Pharmacodynamic (PD) Biomarkers Revenue, 2023-2028
  4.2.3 By Type - Global Pharmacodynamic (PD) Biomarkers Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Pharmacodynamic (PD) Biomarkers Market Size, 2021 & 2028
  5.1.2 Diagnostics
  5.1.3 Drug Discovery
  5.1.4 Personalized Medicine
  5.1.5 Others
5.2 By Application - Global Pharmacodynamic (PD) Biomarkers Revenue & Forecasts
  5.2.1 By Application - Global Pharmacodynamic (PD) Biomarkers Revenue, 2017-2022
  5.2.2 By Application - Global Pharmacodynamic (PD) Biomarkers Revenue, 2023-2028
  5.2.3 By Application - Global Pharmacodynamic (PD) Biomarkers Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Pharmacodynamic (PD) Biomarkers Market Size, 2021 & 2028
6.2 By Region - Global Pharmacodynamic (PD) Biomarkers Revenue & Forecasts
  6.2.1 By Region - Global Pharmacodynamic (PD) Biomarkers Revenue, 2017-2022
  6.2.2 By Region - Global Pharmacodynamic (PD) Biomarkers Revenue, 2023-2028
  6.2.3 By Region - Global Pharmacodynamic (PD) Biomarkers Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Pharmacodynamic (PD) Biomarkers Revenue, 2017-2028
  6.3.2 US Pharmacodynamic (PD) Biomarkers Market Size, 2017-2028
  6.3.3 Canada Pharmacodynamic (PD) Biomarkers Market Size, 2017-2028
  6.3.4 Mexico Pharmacodynamic (PD) Biomarkers Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Pharmacodynamic (PD) Biomarkers Revenue, 2017-2028
  6.4.2 Germany Pharmacodynamic (PD) Biomarkers Market Size, 2017-2028
  6.4.3 France Pharmacodynamic (PD) Biomarkers Market Size, 2017-2028
  6.4.4 U.K. Pharmacodynamic (PD) Biomarkers Market Size, 2017-2028
  6.4.5 Italy Pharmacodynamic (PD) Biomarkers Market Size, 2017-2028
  6.4.6 Russia Pharmacodynamic (PD) Biomarkers Market Size, 2017-2028
  6.4.7 Nordic Countries Pharmacodynamic (PD) Biomarkers Market Size, 2017-2028
  6.4.8 Benelux Pharmacodynamic (PD) Biomarkers Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Pharmacodynamic (PD) Biomarkers Revenue, 2017-2028
  6.5.2 China Pharmacodynamic (PD) Biomarkers Market Size, 2017-2028
  6.5.3 Japan Pharmacodynamic (PD) Biomarkers Market Size, 2017-2028
  6.5.4 South Korea Pharmacodynamic (PD) Biomarkers Market Size, 2017-2028
  6.5.5 Southeast Asia Pharmacodynamic (PD) Biomarkers Market Size, 2017-2028
  6.5.6 India Pharmacodynamic (PD) Biomarkers Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Pharmacodynamic (PD) Biomarkers Revenue, 2017-2028
  6.6.2 Brazil Pharmacodynamic (PD) Biomarkers Market Size, 2017-2028
  6.6.3 Argentina Pharmacodynamic (PD) Biomarkers Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Pharmacodynamic (PD) Biomarkers Revenue, 2017-2028
  6.7.2 Turkey Pharmacodynamic (PD) Biomarkers Market Size, 2017-2028
  6.7.3 Israel Pharmacodynamic (PD) Biomarkers Market Size, 2017-2028
  6.7.4 Saudi Arabia Pharmacodynamic (PD) Biomarkers Market Size, 2017-2028
  6.7.5 UAE Pharmacodynamic (PD) Biomarkers Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Thermo Fisher Scientific
  7.1.1 Thermo Fisher Scientific Corporate Summary
  7.1.2 Thermo Fisher Scientific Business Overview
  7.1.3 Thermo Fisher Scientific Pharmacodynamic (PD) Biomarkers Major Product Offerings
  7.1.4 Thermo Fisher Scientific Pharmacodynamic (PD) Biomarkers Revenue in Global Market (2017-2022)
  7.1.5 Thermo Fisher Scientific Key News
7.2 Merck
  7.2.1 Merck Corporate Summary
  7.2.2 Merck Business Overview
  7.2.3 Merck Pharmacodynamic (PD) Biomarkers Major Product Offerings
  7.2.4 Merck Pharmacodynamic (PD) Biomarkers Revenue in Global Market (2017-2022)
  7.2.5 Merck Key News
7.3 Bio-Rad Laboratories
  7.3.1 Bio-Rad Laboratories Corporate Summary
  7.3.2 Bio-Rad Laboratories Business Overview
  7.3.3 Bio-Rad Laboratories Pharmacodynamic (PD) Biomarkers Major Product Offerings
  7.3.4 Bio-Rad Laboratories Pharmacodynamic (PD) Biomarkers Revenue in Global Market (2017-2022)
  7.3.5 Bio-Rad Laboratories Key News
7.4 QIAGEN
  7.4.1 QIAGEN Corporate Summary
  7.4.2 QIAGEN Business Overview
  7.4.3 QIAGEN Pharmacodynamic (PD) Biomarkers Major Product Offerings
  7.4.4 QIAGEN Pharmacodynamic (PD) Biomarkers Revenue in Global Market (2017-2022)
  7.4.5 QIAGEN Key News
7.5 Roche
  7.5.1 Roche Corporate Summary
  7.5.2 Roche Business Overview
  7.5.3 Roche Pharmacodynamic (PD) Biomarkers Major Product Offerings
  7.5.4 Roche Pharmacodynamic (PD) Biomarkers Revenue in Global Market (2017-2022)
  7.5.5 Roche Key News
7.6 Danaher Corporation
  7.6.1 Danaher Corporation Corporate Summary
  7.6.2 Danaher Corporation Business Overview
  7.6.3 Danaher Corporation Pharmacodynamic (PD) Biomarkers Major Product Offerings
  7.6.4 Danaher Corporation Pharmacodynamic (PD) Biomarkers Revenue in Global Market (2017-2022)
  7.6.5 Danaher Corporation Key News
7.7 Siemens Healthcare
  7.7.1 Siemens Healthcare Corporate Summary
  7.7.2 Siemens Healthcare Business Overview
  7.7.3 Siemens Healthcare Pharmacodynamic (PD) Biomarkers Major Product Offerings
  7.7.4 Siemens Healthcare Pharmacodynamic (PD) Biomarkers Revenue in Global Market (2017-2022)
  7.7.5 Siemens Healthcare Key News
7.8 Abbott
  7.8.1 Abbott Corporate Summary
  7.8.2 Abbott Business Overview
  7.8.3 Abbott Pharmacodynamic (PD) Biomarkers Major Product Offerings
  7.8.4 Abbott Pharmacodynamic (PD) Biomarkers Revenue in Global Market (2017-2022)
  7.8.5 Abbott Key News
7.9 Agilent Technologies
  7.9.1 Agilent Technologies Corporate Summary
  7.9.2 Agilent Technologies Business Overview
  7.9.3 Agilent Technologies Pharmacodynamic (PD) Biomarkers Major Product Offerings
  7.9.4 Agilent Technologies Pharmacodynamic (PD) Biomarkers Revenue in Global Market (2017-2022)
  7.9.5 Agilent Technologies Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Pharmacodynamic (PD) Biomarkers Market Opportunities & Trends in Global Market
Table 2. Pharmacodynamic (PD) Biomarkers Market Drivers in Global Market
Table 3. Pharmacodynamic (PD) Biomarkers Market Restraints in Global Market
Table 4. Key Players of Pharmacodynamic (PD) Biomarkers in Global Market
Table 5. Top Pharmacodynamic (PD) Biomarkers Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Pharmacodynamic (PD) Biomarkers Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Pharmacodynamic (PD) Biomarkers Revenue Share by Companies, 2017-2022
Table 8. Global Companies Pharmacodynamic (PD) Biomarkers Product Type
Table 9. List of Global Tier 1 Pharmacodynamic (PD) Biomarkers Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pharmacodynamic (PD) Biomarkers Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Pharmacodynamic (PD) Biomarkers Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Pharmacodynamic (PD) Biomarkers Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Pharmacodynamic (PD) Biomarkers Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Pharmacodynamic (PD) Biomarkers Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Pharmacodynamic (PD) Biomarkers Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Pharmacodynamic (PD) Biomarkers Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Pharmacodynamic (PD) Biomarkers Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Pharmacodynamic (PD) Biomarkers Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Pharmacodynamic (PD) Biomarkers Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Pharmacodynamic (PD) Biomarkers Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Pharmacodynamic (PD) Biomarkers Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Pharmacodynamic (PD) Biomarkers Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Pharmacodynamic (PD) Biomarkers Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Pharmacodynamic (PD) Biomarkers Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Pharmacodynamic (PD) Biomarkers Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Pharmacodynamic (PD) Biomarkers Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Pharmacodynamic (PD) Biomarkers Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Pharmacodynamic (PD) Biomarkers Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Pharmacodynamic (PD) Biomarkers Revenue, (US$, Mn), 2023-2028
Table 30. Thermo Fisher Scientific Corporate Summary
Table 31. Thermo Fisher Scientific Pharmacodynamic (PD) Biomarkers Product Offerings
Table 32. Thermo Fisher Scientific Pharmacodynamic (PD) Biomarkers Revenue (US$, Mn), (2017-2022)
Table 33. Merck Corporate Summary
Table 34. Merck Pharmacodynamic (PD) Biomarkers Product Offerings
Table 35. Merck Pharmacodynamic (PD) Biomarkers Revenue (US$, Mn), (2017-2022)
Table 36. Bio-Rad Laboratories Corporate Summary
Table 37. Bio-Rad Laboratories Pharmacodynamic (PD) Biomarkers Product Offerings
Table 38. Bio-Rad Laboratories Pharmacodynamic (PD) Biomarkers Revenue (US$, Mn), (2017-2022)
Table 39. QIAGEN Corporate Summary
Table 40. QIAGEN Pharmacodynamic (PD) Biomarkers Product Offerings
Table 41. QIAGEN Pharmacodynamic (PD) Biomarkers Revenue (US$, Mn), (2017-2022)
Table 42. Roche Corporate Summary
Table 43. Roche Pharmacodynamic (PD) Biomarkers Product Offerings
Table 44. Roche Pharmacodynamic (PD) Biomarkers Revenue (US$, Mn), (2017-2022)
Table 45. Danaher Corporation Corporate Summary
Table 46. Danaher Corporation Pharmacodynamic (PD) Biomarkers Product Offerings
Table 47. Danaher Corporation Pharmacodynamic (PD) Biomarkers Revenue (US$, Mn), (2017-2022)
Table 48. Siemens Healthcare Corporate Summary
Table 49. Siemens Healthcare Pharmacodynamic (PD) Biomarkers Product Offerings
Table 50. Siemens Healthcare Pharmacodynamic (PD) Biomarkers Revenue (US$, Mn), (2017-2022)
Table 51. Abbott Corporate Summary
Table 52. Abbott Pharmacodynamic (PD) Biomarkers Product Offerings
Table 53. Abbott Pharmacodynamic (PD) Biomarkers Revenue (US$, Mn), (2017-2022)
Table 54. Agilent Technologies Corporate Summary
Table 55. Agilent Technologies Pharmacodynamic (PD) Biomarkers Product Offerings
Table 56. Agilent Technologies Pharmacodynamic (PD) Biomarkers Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Pharmacodynamic (PD) Biomarkers Segment by Type in 2021
Figure 2. Pharmacodynamic (PD) Biomarkers Segment by Application in 2021
Figure 3. Global Pharmacodynamic (PD) Biomarkers Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Pharmacodynamic (PD) Biomarkers Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Pharmacodynamic (PD) Biomarkers Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pharmacodynamic (PD) Biomarkers Revenue in 2021
Figure 8. By Type - Global Pharmacodynamic (PD) Biomarkers Revenue Market Share, 2017-2028
Figure 9. By Application - Global Pharmacodynamic (PD) Biomarkers Revenue Market Share, 2017-2028
Figure 10. By Region - Global Pharmacodynamic (PD) Biomarkers Revenue Market Share, 2017-2028
Figure 11. By Country - North America Pharmacodynamic (PD) Biomarkers Revenue Market Share, 2017-2028
Figure 12. US Pharmacodynamic (PD) Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Pharmacodynamic (PD) Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Pharmacodynamic (PD) Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Pharmacodynamic (PD) Biomarkers Revenue Market Share, 2017-2028
Figure 16. Germany Pharmacodynamic (PD) Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 17. France Pharmacodynamic (PD) Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Pharmacodynamic (PD) Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Pharmacodynamic (PD) Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Pharmacodynamic (PD) Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Pharmacodynamic (PD) Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Pharmacodynamic (PD) Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Pharmacodynamic (PD) Biomarkers Revenue Market Share, 2017-2028
Figure 24. China Pharmacodynamic (PD) Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Pharmacodynamic (PD) Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Pharmacodynamic (PD) Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Pharmacodynamic (PD) Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 28. India Pharmacodynamic (PD) Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Pharmacodynamic (PD) Biomarkers Revenue Market Share, 2017-2028
Figure 30. Brazil Pharmacodynamic (PD) Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Pharmacodynamic (PD) Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Pharmacodynamic (PD) Biomarkers Revenue Market Share, 2017-2028
Figure 33. Turkey Pharmacodynamic (PD) Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Pharmacodynamic (PD) Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Pharmacodynamic (PD) Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Pharmacodynamic (PD) Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 37. Thermo Fisher Scientific Pharmacodynamic (PD) Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Merck Pharmacodynamic (PD) Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bio-Rad Laboratories Pharmacodynamic (PD) Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. QIAGEN Pharmacodynamic (PD) Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Roche Pharmacodynamic (PD) Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Danaher Corporation Pharmacodynamic (PD) Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Siemens Healthcare Pharmacodynamic (PD) Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Abbott Pharmacodynamic (PD) Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Agilent Technologies Pharmacodynamic (PD) Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)